Zai Lab Gets FDA Orphan Drug Designation For ZL-1310 To Treat Small Cell Lung Cancer
Zai Lab Limited (ZLAB) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation or ODD to ZL-1310, a ...
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan ...
GlobalData on MSN9h
FDA grants ODD status to Zai Lab’s lung cancer treatment
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).
Le Lézard18h
Bybit P2P's Third Anniversary Celebration Culminates in Rewards Bonanza
Bybit, the world's second-largest cryptocurrency exchange by trading volume, officially marks the 3rd anniversary of its P2P ...
Le Lézard19h
THE FIRST-EVER EIGHT-COUNTRY HOLOCAUST KNOWLEDGE AND AWARENESS INDEX SHOWS GROWING GAP IN KNOWLEDGE ABOUT THE HOLOCAUST, ESPECIALLY IN YOUNG ADULTS
The Conference on Jewish Material Claims Against Germany (Claims Conference) today released the first-ever, eight-country Index on Holocaust Knowledge and Awareness, exposing a global trend in fading ...
Macau Business11h
Corero Network Security Enhances UK Dedicated Servers’ DDoS Defense with High-Performance Upgrade
UK Dedicated Servers Strengthens Partnership with Corero as First EMEA Adopter of New Adaptive NTD3400 DDoS Solution. MARLBOROUGH, Mass., Jan. /PRNewswire/ — Corero Net ...